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Cells rely on a diverse repertoire of genes for maintaining homeostasis, but the transcriptional
networks underlying their expression remain poorly understood. The MOF acetyltransferase-
containing Non-Specific Lethal (NSL) complex is a broad transcription regulator. It is essential
in Drosophila, and haploinsufficiency of the human KANSL1 subunit results in the Koolen-de
Vries syndrome. Here, we perform a genome-wide RNAi screen and identify the BET protein
BRD4 as an evolutionary conserved co-factor of the NSL complex. Using Drosophila and
mouse embryonic stem cells, we characterise a recruitment hierarchy, where NSL-deposited
histone acetylation enables BRD4 recruitment for transcription of constitutively active genes.
Transcriptome analyses in Koolen-de Vries patient-derived fibroblasts reveals perturbations
with a cellular homeostasis signature that are evoked by the NSL complex/BRD4 axis. We
propose that BRD4 represents a conserved bridge between the NSL complex and tran-
scription activation, and provide a new perspective in the understanding of their functions in
healthy and diseased states.
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Chromatin modifications shape the gene expression pat-terns of a cell1. Loss of epigenetic regulators can lead tochromatin and transcriptional rewiring, and thus alter
cellular identity and function. In humans, misregulation and
mutation of epigenetic regulators have a significant pathological
potential that can lead to e.g. developmental disorders or
cancers2,3. While diagnosis of such diseases is greatly improving,
for example due to the advances of next-generation sequencing4,
the relevant molecular understanding to establish a therapeutic
approach is often missing. This remains particularly challenging
for broadly expressed regulators, where the co-factors instructing
their activity on ubiquitous versus tissue-specific target genes,
remain often poorly defined. The MOF acetyltransferase-
containing NSL complex is a major regulator of constitutively
expressed genes in both flies and mammals. The NSL complex is
essential for viability and conserved from flies to humans5. Het-
erozygous mutations in KANSL1, a subunit of the NSL complex,
are causative for the Koolen-de Vries syndrome6,7, which shows a
prevalence of 1/16000, and is characterised by mild to moderate
intellectual disability and co-morbidities including cardiac
abnormalities and craniofacial defects6–8. Mutations in other
subunits of the NSL complex including MOF9 and KANSL210 are
also associated with intellectual disability.
The spectrum of the NSL target genes encompasses diverse
cellular functions from cell cycle to metabolism11–14. Tethering of
the NSL complex to a reporter gene triggers strong transcription
activation15. The NSL complex interacts with the NURF chro-
matin remodelling complex to ensure proper nucleosome posi-
tioning for accurate TSS selection16. However, a comprehensive
picture of how the NSL complex, potentially with partner pro-
teins, achieves transcription activation in flies or mammals is still
missing.
The reduced molecular and genetic complexity of the Droso-
phila model system provides a powerful tool to interrogate reg-
ulatory networks of disease-relevant genes17. In the current study,
we utilize Drosophila to generate a functional NSL complex
interactome. We uncover an evolutionarily conserved functional
interaction between the NSL complex and the BET protein BRD4
in transcription. Our work reveals an unexpected BET protein
signature in patients with haploinsufficiency of KANSL1, which
underlies the Koolen-de Vries intellectual disability syndrome.
Results
RNAi screen identifies functional NSL complex interactome.
The NSL complex is required for the proper expression of around
6000 genes in Drosophila16, yet the mechanism by which it
facilitates transcription remains unclear. We undertook an
unbiased approach to identify the full functional interaction
spectrum of the NSL complex in Drosophila. To this end, we
performed a genome-wide RNAi screen based on a luciferase
reporter assay in cultured cells, where tethering of NSL3, a sub-
unit of the NSL complex, to a minimal promoter through a Gal4-
DNA-binding domain conveys strong transcriptional activity15
(Fig. 1a, Supplementary Fig. 1a). This assay was sensitive to
depletion of other NSL complex members (Supplementary
Fig. 1b), hence NSL1, NSL3 and MOF served as positive controls
for the genome-wide screen. We used the Drosophila Heidelberg
(HD2) library, which spans ~99% of the Drosophila protein-
coding genome (14587 genes)18. Our assay allowed for detection
of quantitive signal changes (Z′-factor= 0.73)19 (Supplementary
Figure 1c). Reassuringly, quality controls were fulfilled (Supple-
mentary Fig. 1c–g) and we scored all seven NSL complex subunits
in the genome-wide screen (Supplementary Fig. 1h), confirming
its capability to detect functionally relevant factors. The screen
provided us with both positive and negative regulators (Fig. 1b,
Supplementary Data 1), with a number of candidates displaying
similar Z-scores as the depletion of MOF.
Based on Z-score thresholds, we selected the 367 top scoring
genes for a secondary screen (Fig. 1b, c). In the secondary screen
we performed two assays; first, we repeated the NSL3-driven
reporter assay, which validated 80% of the rescreened candidates
(Fig. 1d); second, we performed a control assay, where trans-
cription activation is induced by the Gal4 activation domain
(Gal4-AD) instead of NSL3. This additional assay enabled us to
distinguish NSL complex-specific co-regulators from candidates
generally involved in transcription and moreover, to control for
Gal4 tethering as such. Among the factors that were scored in
both NSL3 and Gal4-AD, we uncovered several components of
the proteasome complex (Fig. 1e).
Several proteins having known functional relationships with
the NSL complex were recovered amongst the screen targets. We
identified the NURF complex (Z-score <−6 for Caf1, E(bx), Iswi)
(Fig. 1f) as a functional modulator of NSL3-driven transcription.
This is consistent with our previous work demonstrating that
functional and physical interactions between the NSL and NURF
complexes are essential for faithful nucleosome positioning at
NSL complex-bound promoters in Drosophila16. Furthermore, we
also scored Chromator (Chro) and Putzig (Pzg), which have both
been reported to co-purify with the NSL complex5,15 and could
possibly relate to a role in genome organization20,21.
The vast majority of targets uncovered by the screen were novel
factors without any previous functional associations with the NSL
complex. For example, we scored multiple subunits of different
chromatin-associated complexes, such as the RNA Polymerase 2
Associated Factor 1 (PAF1) (Z-score <−6 for Atms, Hyx), TIP60
(Z-score <−6 for Dom, E(pc), Act87E, Bap55, His2Av) and the
Myb/dREAM complex (Z-score <−6 for Caf1, Dp, Mip120,
Mip130) (Fig. 1f). Furthermore, components of the SCF-slmb
complex (Z-score <−6 for all components) and the PP2A
complex (Z-score <−6 for Mts, Pp2A-29B, Pp2A-B′, Tws) were
scored. These complexes harbour enzymes responsible for protein
ubiquitination and dephosphorylation, respectively22,23. Using
the Search Tool for the Retrieval of Interacting Genes/Proteins
(STRING) database of physical and functional interactions24,
we found that the targets identified from the screen show
significantly higher network connectivity than expected by
random chance (p-value < 1.0e-16) (Supplementary Fig. 2). More-
over, we identified categories such as hippo signalling, hedgehog
signalling, spliceosome and ubiquitin mediated proteolysis as
overrepresented.
One of the highest scoring candidates in our screen was
dBRD4/fs(1)h (Fig. 1b, e, f), the only Bromodomain and Extra
Terminal Domain (BET) family protein in Drosophila25. dBRD4,
like BRD4 in mammals, produces two distinct isoforms (long
isoform dBRD4-L and short isoform dBRD4-S), that both
associate with chromatin25. BRD4 promotes productive elonga-
tion by recruiting P-TEFb, which phosphorylates RNA Polymer-
ase 2 (Pol2)26. Furthermore, BRD4 has been shown to associate
with multiple developmental transcription factors such as Myc,
IRF4 and PRDM1 in health and disease27–29. Given that the NSL
complex predominantly regulates constitutively expressed genes,
we were curious to understand how it could be functionally
related to an established regulator of inducible gene expression
such as BRD4.
The NSL complex and dBRD4 colocalize on endogenous pro-
moters. We observed a strong (>75%) and reproducible decrease
of NSL3-driven luciferase reporter expression following dBRD4
RNAi in our pilot, genome-wide and secondary screens (Fig. 2a).
To validate the functional interaction between the NSL complex
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and dBRD4 in an endogenous context, we examined their
genome-wide distributions in S2 cells. A comparison between
publicly available dBRD425 and NSL313 ChIP-seq binding profiles
showed that a remarkable 86% of NSL3-bound promoters were
co-occupied by dBRD4 (calculation based on MACS peaks, p-
value < 2.2e-16) (Fig. 2b, c). This extensive co-localization of
NSL3 and dBRD4 on chromatin was further confirmed by
immunofluorescence staining of polytene chromosomes in
dBRD4-L expressing transgenic flies (Fig. 2d). Gene Ontology
(GO) enrichment analysis on gene promoters co-occupied by
both NSL3 and dBRD4 revealed biological processes such as
Cellular Metabolism, RNA processing, Intracellular Transport
and Biosynthesis (Fig. 2e). Many of these overlap with GO terms
associated with NSL complex targets11–13,30. This analysis
therefore uncovered two unexpected findings. First, that the
majority of NSL complex and dBRD4 genome-wide gene targets
are common. Second, that dBRD4 displays binding to genes
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that dBRD4 has a far more significant contribution to their reg-
ulation than was previously anticipated.
dBRD4 promotes transcription elongation of NSL target genes.
Given the significant overlap between dBRD4 and NSL complex
target genes, we wanted to determine the relevance of their shared
occupancy for transcription. A number of small molecule inhi-
bitors of BET proteins, including JQ1 and iBET are available31,32.
Furthermore, thalidomide-conjugated JQ1 molecules (dBET) that
permit rapid degradation of BET proteins in mammalian cells
have recently been generated33. JQ1 has been shown to be
functional in Drosophila25. We observed that treating Drosophila
cells with dBET led to the complete degradation of dBRD4 within
4 h (Fig. 3a). These small molecule inhibitors thus provide an
opportunity to study the effect of acute loss of dBRD4 function
independent of the secondary effects that can arise from RNAi
treatment. We detected a substantial decrease in NSL3-driven
reporter gene expression in cells treated with JQ1, iBET or dBET,
with stronger effects observed upon longer treatment (16 h vs.
9 h) (Fig. 3b–d, Supplementary Fig. 3a–c). Conversely, the Gal4-
driven control reporter activity rather increased (Fig. 3b–d,
Supplementary Fig. 3a–c). This indicates that the transcriptional
effects of dBRD4 loss are specifically mediated through functional
crosstalk with the NSL complex and do not arise as a result of a
global expression defect. We observed a similar response when
tethering the human orthologue of NSL3, KANSL3, to the pro-
moter of the luciferase reporter in Drosophila cells, suggesting
that the transcriptional link between dBRD4 and the NSL com-
plex is evolutionarily conserved (Fig. 3b–d, Supplementary
Fig. 3a–c).
Having shown that depletion or inhibition of dBRD4 reduces
NSL3-dependent transcription of a luciferase reporter, we next
probed the effects of dBRD4 loss on endogenous NSL target
genes. We undertook total RNA-seq experiments in S2 cells after
NSL1, NSL3, dBRD4 and control (GST) RNAi as well as 1 h JQ1,
4 h JQ1 and DMSO treatment (Fig. 3e). Depletion of NSL
complex members and JQ1 treatment affected the expression of
thousands of genes (Fig. 3e, Supplementary Fig. 3d, e), and
consequently standard RNA-seq normalization methods could
not be applied. Instead, we normalized the RNA-seq data to
External RNA Controls Consortium (ERCC) spikes that were
added prior to library generation. Using this analysis, we scored
7362 differentially expressed (DE) genes for NSL1 RNAi, 5995 DE
genes for NSL3 RNAi, 3503 DE genes for dBRD4 RNAi, 3835 DE
genes for 1 h JQ1 and 6609 DE genes for 4 h JQ1 (false discovery
rate (FDR) < 0.05) (Supplementary Data 2). Consistent with its
role as a transcriptional activator, NSL complex-bound targets
were downregulated upon NSL1 RNAi (p-value= 1.2e−7) (Fig. 3f,
Supplementary Fig. 3f). As expected, there was significant
correlation between DE genes scored upon NSL1 and NSL3
RNAi (adj R2= 0.56). We validated the RNA-seq results using
RT-qPCR measurements (Supplementary Fig. 3g, h). In agree-
ment with previous findings25, we detected a smaller number of
differentially expressed genes upon dBRD4 RNAi compared to
dBRD4 inhibition (Supplementary Fig. 3g, h). This may be a
consequence of adaptation of the cells during the four days
of RNAi.
From the global RNA-seq experiments, we uncovered a
significant correlation between gene expression changes observed
upon depletion of NSL1 and inhibition of dBRD4 by JQ1 (4 h) (adj
R2= 0.20, Fig. 3g). In fact, 84% of the genes that were differentially
downregulated upon NSL1 RNAi were also differentially down-
regulated following 4 h of JQ1 treatment (Fig. 3e). Likewise, NSL
complex-bound genes were significantly downregulated after
knockdown of either the long isoform or both isoforms of dBRD4
using RNAi (Fig. 3f, Supplementary Fig. 3f), whereas genes not
bound by the NSL complex were not significantly affected
(Supplementary Fig. 3f). These correlations suggest that dBRD4
and the NSL complex not only co-occupy the same target genes but
also cooperate in enabling their transcription.
As an important control, we checked the protein levels of NSL
complex members after dBRD4 RNAi. We did not observe any
change in the stability of several NSL complex components after
dBRD4 depletion. Conversely, dBRD4 protein levels also did not
change upon NSL1, NSL3 or MOF RNAi (Supplementary Fig. 3i).
This supports the idea that dBRD4 affects NSL target gene
expression through transcriptional interplay with NSL complex
members and not by affecting NSL protein levels.
We were interested in pinpointing which steps of transcription
were influenced by dBRD4 inhibition. We had previously
reported that depletion of the NSL complex affects the
recruitment of RNA Pol2 to promoters13. In line with previous
findings, cells depleted of NSL1 showed a bulk decrease in both
Pol2 serine-5 phosphorylation (Pol2 ser5p), which is associated
with transcription initiation, and Pol2 serine-2 phosphorylation
(Pol2 ser2p), which is associated with transcription elongation
(Fig. 3h). In contrast, treating cells with JQ1 or dBET only led to a
decrease in Pol2 ser2p, while Pol2 ser5p remained largely
unaffected (Fig. 3i, Supplementary Fig. 3j). To determine, whether
these bulk-level effects were reflected in transcriptional changes at
NSL target genes, we assessed RNA Pol2 occupancy by Rpb3
ChIP-seq in cells treated with JQ1 or dBET (Fig. 3j). Inhibition or
degradation of dBRD4 led to a moderate increase of total Pol2 at
promoters and a decrease in occupancy throughout the gene
bodies. These effects were more pronounced for NSL-bound
genes compared to expressed, NSL-non-bound genes (Fig. 3j). In
Fig. 1 RNAi screen identifies functional NSL complex interactome. a Scheme of primary genome-wide screen. Plasmids containing a fusion construct, nsl3
gene fused to Gal4 DNA-binding domain (Gal4-DBD), a firefly luciferase reporter containing Gal4 DNA-binding upstream activating sequence elements
(5xUAS) and a constitutively active hsp70 Renilla luciferase reporter were co-transfected into S2 cells. Effect of RNAi of a candidate (X) on reporter signal
is assayed. Renilla signal serves a control for transfection efficiency. b Data distribution of primary RNAi screen. Scatterplot of Z-scores and luciferase
signal (average of two replicates) are plotted for each knockdown (within the Z-score range of −70 to +6). Data points from grey shaded areas were used
for secondary screen. Grey datapoints: candidates excluded due to strong effect on Renilla signal (see Methods for more details on filtering and analysis of
RNAi screen), orange datapoints: positive control knockdowns, blue datapoints: negative control knockdowns (GST, GFP and Diap1), green triangles: other
candidates (dBRD4, Nurf complex and PAF complex). c Scheme of secondary screen reporter assay. Upper part as in a, lower part: Gal4-DBD fused to Gal4
activation domain (Gal4-AD) represents the canonical full length Gal4. Full length Gal4 it is used as control, to discriminate NSL unspecific transcription
factors. d Venn diagram depicting overlap of candidates that scored in the primary and secondary Nsl3-Gal4-DBD screens. The same thresholds for firefly
luciferase signal relative to Renilla luciferase signal were applied for both primary and secondary screens. e Heatmap of log-scaled fold changes of
normalized luciferase signal in the primary and secondary RNAi screens. Results for the 367 knockdowns performed in the secondary assays are plotted.
The order of genes was generated by unsupervised hierarchical clustering. f Z-scores of genome-wide RNAi screen for several complexes and protein
categories are listed. If a gene was targeted by multiple dsRNAs, an average of the respective Z-scores is given.
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contrast, depletion of NSL1 affected both the promoters and gene
bodies of NSL-bound genes. These changes are unlikely to be a
consequence of ChIP efficiency or normalization, as the spiked-in
Drosophila virilis chromatin was equally recovered in controls
and inhibitor-treated cells (see Methods). We conclude that RNA
Pol2 elongation is defective at NSL-bound genes when dBRD4
is inhibited or degraded. Our data furthermore suggest, that
the NSL complex and dBRD4 collaborate in a functional relay
coupling Pol2 transcription initiation and elongation events on
NSL target genes.
Efficient recruitment of dBRD4 requires the NSL complex. The
transcriptional effects observed upon loss of dBRD4 and the NSL
complex implied that dBRD4 recruitment requires the NSL
complex. To test this hypothesis, we performed dBRD4 ChIP-seq
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Fig. 2 The NSL complex and dBRD4 colocalize on endogenous promoters. a Barplot of mean firefly signal normalized to Renilla signal and control RNAi
(GST) of each knockdown and screen (two replicates). Source data are provided as a Source Data file. b Heatmaps and summary plots of NSL313 and
dBRD425 ChIP profiles. Log2 fold changes over input are plotted for all genes. Genes of both heatmaps are clustered and sorted based on NSL3 ChIP signal.
p-value < 2.2e-16 for one-sided Fisher’s Exact Test on overrepresentation of dBRD4 binding on NSL3-bound promoters. c Scatterplot of NSL313 and dBRD425
ChIP signals on gene promoters (TSS ± 200bp). Log2 fold changes over input are plotted for all gene promoters. R2 was calculated with linear regression
model. d Polytene chromosome immunostaining of daGal4 >UAS-fs(1)h-L-HA third instar larvae. NSL3 staining in red, HA staining in green: tagged long
isoform of dBRD4 (dBRD4-L-HA). Scale bar: 5 µm. This experiment was repeated independently two more times showing similar results. e Gene Ontology
(GO) Enrichment analysis of Biological Processes of genes promoter-bound by both dBRD4 and NSL3. Promoter-bound genes were defined by MACS peak
calling on dBRD425 and NSL313 ChIP-seq datasets considering TSS ± 200 bp as promoter region. Enriched GO terms were visualized with REVIGO.
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cell line expressing the FLAG-His-Bio-His tagged short isoform
of dBRD4 (dBRD4-S-Biotin)34 under the control of an inducible
MtnA promoter. This enabled us to use stringent wash conditions
and untagged controls, while inducing the tagged protein at
similar levels across different conditions (Supplementary Fig. 4a,
b). We used exogenous biotinylated DNA spikes to control for
ChIP efficiencies in the different RNAi conditions (see Methods).
We performed peak calling for both the dBRD4-S-Biotin and the
dBRD4 antibody ChIP data25. We identified 2491 dBRD4-S-
Biotin-bound promoters (Supplementary Fig. 4c, d), which
represents a large subset of the 4525 dBRD4 antibody ChIP-
associated promoters. The biotin ChIP-seq experiments revealed
a robust decrease of dBRD4 occupancy following NSL1 and MOF
RNAi (Fig. 4a) at the majority of dBRD4-S-Biotin-bound pro-
moters, while binding at few sites remained unaffected
(Supplementary Fig. 4e). Changes in dBRD4 occupancy were
most striking for NSL1 RNAi followed by MOF RNAi (Fig. 4a–c;
qPCR validation in Fig. 4d).
To determine whether dBRD4 depletion in turn affects NSL
complex occupancy, we performed the reciprocal ChIP-qPCR
experiments for NSL1 and MOF after JQ1 treatment, dBET
treatment or dBRD4 RNAi. We assessed their enrichment at
promoters of genes that showed decreased expression levels upon
both NSL1 RNAi and JQ1 treatment (Supplementary Fig. 4f).
There was no decrease of NSL1 or MOF occupancy at any of the
tested genes after treatment with JQ1 or dBET or after dBRD4
RNAi (Fig. 4e–g, Supplementary Fig. 4g, h). Together with the
dBRD4 ChIP analyses, these results suggest that the NSL complex
functions upstream of dBRD4. While the NSL complex is
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NSL complex and dBRD4 are necessary for productive transcrip-
tion. This is confirmed by our observation that gene expression is
abolished in the absence of dBRD4, even if the NSL complex is
still bound at the respective gene promoters (Fig. 3).
NSL complex-mediated acetylation leads to dBRD4 recruit-
ment. The NSL complex harbors histone acetyltransferase activity
in the form of its enzymatic member MOF. In the context of the
NSL complex, MOF not only catalyzes the acetylation of H4K16,
but also of H4K5, K8 and K12 in vitro30,35. As BET proteins are
capable of recognizing acetylated histone residues36,37, we wanted
to investigate whether this mark represents the link between the
NSL complex and dBRD4. While the affinity of bromodomains
towards mono acetylated histones is modest, it increases with the
presence of multiple acetylated residues in tandem36,38,39. We
therefore tested whether the different H4 tail modifications,
which can be catalyzed by MOF, would directly impact on the
binding affinity of dBRD4 to the H4 tail in vitro.
To this end, we performed biolayer interferometry measure-
ments. We expressed dBRD4-S in bacteria and quantified its
binding to N-terminal histone H4 peptides harboring different
acetylation patterns (see Methods for details). As controls, we used
bacteria expressing the histone H3 lysine 9 methylation-specific
reader HP1SWI6, as well as uninduced bacteria that do not express
any recombinant protein (Supplementary Fig. 5a). The assay
revealed a strong binding of dBRD4-S to the multi-acetylated
H4K5,8,12,16ac peptide and an intermediate binding affinity to the
di-acetylated H4K12,16ac peptide. The binding to the mono-
acetylated peptides H4K12ac and H4K16ac was weaker and
comparable to the background signal of the uninduced control
(Supplementary Fig. 5b, c), which is consistent with previously
published data on bromodomain binding affinities36. Furthermore,
these binding events occurred in a dBRD4-dependent fashion, since
lowering its concentration by dilution with uninduced extracts led
to a concordant reduction of the detected binding signal
(Supplementary Fig. 5c). Importantly, HP1SWI6 did not display
binding to any of the acetylated histone H4 peptides tested
(Supplementary Fig. 5c), which confirms the specificity of our
experimental setup. These results demonstrate that NSL-mediated
H4 tail modifications, including H4K16ac can be recognized by
dBRD4 and as for other bromodomain proteins, the presence of
multiple acetylations promotes its binding to the histone tail.
To investigate whether NSL deposited histone acetylation
provides the connection to dBRD4 recruitment in vivo, we
performed H4K16ac and H3 ChIP-seq experiments in control
and NSL1 RNAi cells. We used H4K16ac as a proxy for NSL-
mediated histone acetylation, as changes in H4K16ac can be
directly linked to MOF, while H4K5, K8 or K12 acetylations can
also be catalyzed by other HATs12,40,41. We compared NSL-
bound and non-bound genes. NSL-bound genes displayed strong
changes in dBRD4-S-Biotin and Pol2 ChIP signal (Fig. 5a).
Similarly, we found that the NSL-bound group also displayed
reduced H4K16ac levels upon NSL1 RNAi (Fig. 5a). Furthermore,
overall H4K16ac levels at promoters positively correlated with
dBRD4 binding (adj R2= 0.25, Supplementary Fig. 5d). These
data suggest that NSL complex-mediated acetylation and dBRD4
recruitment may indeed be linked in vivo.
We designed a rescue experiment to test the requirement of
NSL complex-mediated histone acetylation for recruitment of
dBRD4 to target promoters. Treating cells with the histone
deacetylase inhibitor (HDACi) panobinostat increased overall
histone acetylation levels, including H4K16ac, in both control and
NSL1 RNAi cells (Supplementary Fig. 5e). This was also reflected
in ChIP-qPCR, where H4K16ac increased on both promoters and
gene ends (Fig. 5b, right panel). Remarkably, we found that
HDACi treatment rescued dBRD4 recruitment in NSL1 RNAi
cells (Fig. 5b, left panel), although the extent of rescue varied
between targets. In contrast, NSL1 and MOF occupancy remained
entirely unaffected by HDACi treatment (Supplementary Fig. 5f,
g). These results demonstrate that a change in acetylation status is
sufficient to elicit recruitment of dBRD4 even in the absence of
the NSL complex.
Together this data suggests that NSL-mediated histone H4
acetylation impacts on chromatin binding of dBRD4 and establishes
a hierarchical NSL/BRD4 axis for transcription activation.
The NSL complex/BRD4 axis is conserved in mice and humans.
Having identified the important role played by the NSL/BRD4
axis in transcription activation of Drosophila genes, we wondered
whether it might also be conserved in mammals. Indeed, we had
observed earlier that BET inhibitors impaired luciferase reporter
activation by a tethered human KANSL3 (Fig. 3b, c). Therefore,
we performed comparative analyses of NSL complex and BRD4
binding profiles in mouse embryonic stem cells (mESC) using
available ChIP-seq datasets11,42,43. BRD4 showed strong binding
to NSL-occupied promoters in mESCs (Supplementary Fig. 6a).
In addition, BRD4 binding patterns appeared overall very similar
between three different cell types of different developmental
stages: ESCs, Embryoid Bodies (EB) and mixed lineage leukemia
(MLL) cells (Supplementary Fig. 6a). Such a pattern would be
expected for a factor regulating constitutive gene expression and
could hint towards a co-regulation with the NSL complex11–13.
To explore this further, we performed expression analysis in
mESCs upon depletion of BRD4 and KANSL2. While Drosophila
Fig. 3 dBRD4 promotes transcription elongation of NSL target genes. aWestern blot for dBRD4 and H3 after 100 nM dBET6 (lanes 2 and 5) or 5 µM JQ1
(lanes 3 and 6) treatment. Blue asterisks indicate dBRD4-S and dBRD4-L. The experiment was repeated twice showing similar results. b–d Firefly
luciferase activity using NSL3 and KANSL3 (human orthologue of NSL3) fused to Gal4 DNA-binding domain or full-length Gal4 to drive expression of the
UAS-firefly luciferase reporter upon (b) 5 µM JQ1, (c) 1 µM iBET 762 or (d) 100 nM dBET6 treatment. Bars represent mean values ± SEM (n= 3 technical
replicates). e Heatmap of total RNA-seq. Log2 fold changes of gene expression in NSL1 and NSL3 RNAi and JQ1 (5 µM) treatments for 1 h or 4 h versus
control RNAi (GST) or DMSO for all expressed genes are plotted. Gene order was generated by unsupervised hierarchical clustering. f Boxplot of
normalized RNA-seq counts in NSL1, dBRD4, dBRD4-L and control RNAi (GST) for NSL complex-bound genes (n= 5600). Two-sided Welch two sample
t-test was applied. Boxplots show median (centre), interquartile-range (box) and minima/maxima (whiskers). g Scatterplot of gene expression changes
after 4 h JQ1 treatment and NSL1 RNAi. Log2 fold changes for all genes are plotted. Linear regression model was applied. h Representative western blot for
Pol2 ser2p, Pol2 ser5p and Rpb3 after NSL1 RNAi (lanes 3 and 4), for quantification see Supplementary Fig. 3j. H4 blot shown here is identical to a.
i Representative western blot for Pol2 ser2p, Pol2 ser5p, Rpb3 and H3 after 100 nM dBET6 (lanes 2 and 5) or 5 µM JQ1 (lanes 3 and 6) treatment, for
quantification see Supplementary Figure 3j. j. Average profiles of Pol2 (Rpb3) ChIP-seq signal for expressed NSL-bound (n= 5600) and expressed non-
NSL-bound (n= 1600) genes after 1 h JQ1 (5 µM), 1 h dBET6 (100 nM) or NSL1 RNAi13 compared to controls (DMSO and GFP RNAi). Gene bodies are
scaled from 0.5 kb until TESs. Drosophila virilis chromatin was added to experimental Drosophila melanogaster chromatin before Rpb3 ChIPs to control for IP
efficiency and library composition effects (see Methods). e–g Expression was normalized using synthetic ERCC spikes (see Methods). n= 3 biological
replicates. Source data for b–d are provided as a Source Data file.
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possess just one BET protein (dBRD4), there are three BET
homologues in mice and humans: BRD2, BRD3 and BRD425. As
the small molecule dBET induces degradation of all BET proteins,
dBET treatment in mammalian cells approximates the loss of
dBRD4 in Drosophila. In turn, we generated CAG-Cre-ERT2
Kansl2fl/fl mESCs for conditional knockout (KO) of Kansl2
(Supplementary Fig. 6b). As the whole NSL complex is required
for transcription activation (Fig. 1f), loss of KANSL2 is expected
to exemplify NSL complex function more generally. We used 2i
media for mESC culture to ensure a naïve state of the cells
throughout the experiments. We compared gene expression
changes by RT-qPCR and observed that different from dBET,
pluripotency (e.g. Nanog) and differentiation (e.g. Cdh2) markers
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However, concordant gene expression changes on NSL-target
genes were detected in both Kansl2 deletion or dBET-treated cells
(Fig. 6a, Supplementary Fig. 6d).
To test whether the gene expression changes are associated
with a loss of targeting of BET proteins, we performed BRD4
ChIP-qPCR experiments in Kansl2 KO and dBET-treated cells.
ChIP-qPCR from dBET-treated cells confirmed the specificity of
the obtained BRD4 ChIP signal. Remarkably, targeting of BRD4
was impaired in the absence of the NSL complex member
KANSL2 (Fig. 6b, Supplementary Fig. 6e).
Since pluripotency is unaffected in this scenario (Supplemen-
tary Fig. 6c), loss of BRD4 occupancy appears to be a specific
consequence of impaired NSL complex function, rather than
through a change in cellular state. The results additionally suggest
that the functional interaction and recruitment hierarchy between
the NSL complex and BRD4 that we characterized in Drosophila
cells is evolutionary conserved in mammalian cells.
The Koolen-de Vries syndrome is a complex neurodevelop-
mental disorder caused by haploinsufficiency of KANSL16,7.
Given the high level of evolutionary conservation in NSL complex
targets between flies and mammals14, we hypothesized that the
BRD4-related gene expression signature would also be evident in
affected individuals. To address this question, we cultured
primary fibroblast cell lines from Koolen-de Vries patients and
healthy controls and performed RNA-seq experiments. Despite
the sizeable heterogeneity between patient samples, we could
detect 198 DE genes (FDR < 0.05, Fig. 6c, Supplementary Data 2,
Supplementary Fig. 7a, b). When looking at directionality of
expression change, we found that genes whose orthologues are
bound by KANSL3 in mESCs had a significantly higher
probability of being downregulated in patient cells (p-value=
4.8e−6). Moreover, we identified a set of conserved target genes,
which were consistently downregulated in Drosophila upon NSL1
RNAi (FDR < 0.05), in mice upon Kansl3 knockdown (FDR <
0.05,11) and in KANSL1-haploinsufficient Koolen-de Vries
patient cells (FDR < 0.4) (Fig. 6d, Supplementary Fig. 7a, b).
The majority of those were direct NSL targets in Drosophila and
mESCs by ChIP and comprised mostly genes involved in
metabolic processes, such as mitochondrial function (e.g.MICU2)
and lipid metabolism (e.g. ABHD3). These results suggest that the
transcriptional role of the NSL complex contributes to expression
deregulation in KANSL1 haploinsufficient patients. We next
investigated the gene expression signature specific to these patient
cells more closely. Pathway analysis revealed broad categories
such as Organismal Injuries and Abnormalities and Cancer as
most significantly affected disease and function categories. In
addition, the gene groups Cellular Movement, Cellular Develop-
ment and Cellular Growth and Proliferation were among the top
10 most deregulated categories (Fig. 6e). Consistent with the
housekeeping gene regulatory function of the NSL complex, these
pathway analyses likely reflect an overall imbalance of cellular
and metabolic homeostasis in KANSL1 haploinsufficient patients.
We then compared Koolen-de Vries syndrome expression profiles
to JQ1-treated MOLT4 cells33 (also see Supplementary Fig. 3e). We
chose this JQ1 dataset, because it contained ERCC spikes for
normalization. We classified genes based on their response to JQ1
into JQ1-up, JQ1-down or JQ1-not DE. We then looked at the
response in these three groups of genes in the Koolen-de Vries
patient fibroblast dataset. We observed that the JQ1-down group is
predictive of a downregulation in the patient cells (p-value= 1.5e−49
vs. not DE group, Fig. 6f, Supplementary Fig. 7c). This overlap of
BET and KANSL signatures was also evident when we classified
transcriptome alterations in patients according to directionality
of the change (up- or downregulation). KANSL3-bound genes
(p-value= 4.8e−06) and JQ1-responsive genes (p-value < 2.2e−16),
were significantly overrepresented in the downregulated group
(Fig. 6g), whereas genes bound by MSL2, a subunit of another
MOF-associated complex, were not overrepresented.
Our findings strongly suggest that the functional interaction
between the NSL complex and BRD4 is evolutionarily conserved
and critical for robust expression of their shared target genes.
Furthermore, we reveal that the NSL complex/BRD4 axis might
represent a clinically relevant and potentially druggable aspect of
NSL complex-associated diseases in humans.
Discussion
In this study, we took advantage of the reduced genetic complexity
of the Drosophila system to screen for functional interaction part-
ners of the NSL complex. Improving our understanding of tran-
scription of NSL target genes is imperative given that
haploinsufficiency of KANSL1 is causative of the debilitating
Koolen-de Vries syndrome. Employing a genome-wide approach,
we revealed the diverse functional interaction network of the NSL
complex in Drosophila. This screen permitted us to identify BRD4
as a critical co-factor for transcriptional activation at NSL target
genes (see model Fig. 7). Herewith, we uncover a previously
underappreciated role of BRD4 in regulation of thousands of con-
stitutively expressed genes, including genes involved in cellular
metabolism, RNA processing and cell cycle. We show that BRD4
and the NSL complex share a common set of target genes, and
reveal that functional cooperation between the NSL complex and
BRD4 is necessary for transcription of these. Mechanistically, the
NSL complex and BRD4 appear to participate in a functional relay,
which guides RNA Pol2 through the initiation-to-elongation tran-
sition. We show that NSL complex binding mediates deposition of
Fig. 4 Efficient recruitment of dBRD4 requires the NSL complex. Experiments addressing dBRD4 targeting were performed in a stable S2 cell line, where
the short isoform of dBRD4 triple tagged with FLAG, His and biotin (dBRD4-S-Biotin) was under the control of a copper-inducible promoter. For all
experiments with this stable cell line, expression of dBRD4-S-Biotin was induced by addition of 1 mM CuSO4 to the medium for 16 h. a Heatmaps and
profile plots of dBRD4-S-Biotin ChIP-seq in control (GST RNAi), NSL1 RNAi, MOF RNAi and WT untagged cells. The upper cluster comprises 2491 dBRD4-
S-Biotin-bound and endogenous dBRD4-bound genes, the lower cluster of a similar number of randomly selected, not dBRD4-S-Biotin-bound genes. Both
clusters are ordered by average intensity of all four ChIP datasets. Input-subtracted ChIP-seq data (merge of two biological replicates) is shown. b Boxplot
of dBRD4-S-Biotin ChIP signal (log2 fold change over input) (merge of two biological replicates) on promoters of dBRD4-S-Biotin-bound genes (n= 2491)
(±200bp from TSS) for the respective RNAi experiment. Boxplots show median (centre), interquartile-range (box) and minima/maxima (whiskers). Two-
sided Welch two sample t-test was applied. c Representative IGV browser snapshots of dBRD4-S-Biotin ChIP-seq profiles in control (GST), NSL1 and MOF
RNAi as well as in WT untagged cells, input-subtracted ChIP-seq data (merge of two biological replicates) is shown. d dBRD4-S-Biotin ChIP-qPCR in
control (GST) and NSL1 RNAi as well as in WT cells serving as untagged control. Primers target the promoters and ends of dBRD4-bound genes. e NSL1
ChIP-qPCR of cells treated with JQ1 (5 µM) or DMSO for 4 h. f NSL1 ChIP-qPCR of cells treated with dBET6 (100 nM) or DMSO for 4 h. g NSL1 ChIP-qPCR
of cells after control (GST) or dBRD4 RNAi treatment. For d–g data are presented as mean values, for d, e n= 2 or 3 biological replicates, for f, g n= 2
biological replicates. e–g Primers target the promoters and ends of NSL complex and dBRD4-bound genes, for expression changes in 4 h JQ1 treatment of
these genes, see Supplementary Fig. 4f. Source data for d–g are provided as a Source Data file.
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H4K16ac at target promoters. The histone acetylation is in turn
required for recruitment of BRD4.
Our genome-wide screen for functional NSL complex inter-
action partners identified a multifaceted functional interaction
network. We find several factors and complexes known to be
involved in transcription elongation: the PAF complex26, Bre1
ubiquitin ligase44 and the NELF complex26. In addition, acute
depletion of dBRD4 lead to transcription elongation defects in
Drosophila, similar to what has been reported in mammalian
cells33. Some of the identified elongation factors, such as the
PAF complex, have been shown to physically interact with
BRD445.
We also identified the TIP60 complex, another chromatin-
associated complex as putative functional interaction partner of
the NSL complex. It is a large multi-subunit complex involved in
chromatin remodelling, histone acetylation and incorporation of
H2A.V, a histone variant which combines functions of mam-
malian H2A.Z and H2A.X46. Depletion of H2A.V alone markedly
reduced NSL complex-mediated transcription and its incorpora-
tion at the 5′ end of genes is thought to facilitate transcription47.
In addition to chromatin components, we identified proteins that
have not been associated with a direct role in transcription, for
example subunits of the SCF-slmb ubiquitin ligase, or the PP2A
phosphatase complexes. Possibly their function for NSL-mediated
H4K16ac ChIP ± HDACi
No tag control
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Fig. 5 NSL complex-mediated acetylation leads to dBRD4 recruitment. a Heatmaps and profile plots of ΔdBRD4-S-Biotin ChIP signal, ΔH4K16ac ChIP
signal and ΔPol2 ChIP signal in control (GST) RNAi versus NSL1 RNAi13, as well as ChIP-seq profiles of MOF, NSL3 and MBDR213. All genes are plotted,
clustered into two groups (clustering by k-means based on MOF, NSL3 and MBDR2 ChIP profiles). Order of genes is maintained for all other heatmaps in
this panel. Signal of two merged replicates for ΔdBRD4-S-Biotin, ΔH4K16ac and ΔPol2 is shown. ΔdBRD4-S-Biotin was calculated as ChIP control-ChIP
RNAi, ΔH4K16ac and ΔPol2 were calculated as log2 fold change (ChIP control over input) − log2 fold change (ChIP RNAi over input). b ChIP-qPCR of
dBRD4-S-Biotin ChIP and H4K16ac ChIP after treatment with DMSO or HDAC inhibitor panobinostat (4 h, 200 nM) in control RNAi (GST) or NSL1 RNAi
cells. Primers target the promoters and ends of dBRD4 and NSL complex-bound genes. Data are presented as mean value of n= 2 biological replicates.
Source data are provided as a Source Data file.
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gene regulation lies rather in signalling to the nucleus or post-
translational regulation of transcription factors. Our results sug-
gest that the NSL complex acts as a chromatin-associated
platform for integrating different signals within the cell. With the
genome-wide screen we have generated a valuable resource. It will
be interesting to dissect interconnections and hierarchies between
the identified co-factors in future studies.
Evidence from crystal structures as well as biochemical data
indicate that BRD4 targeting to chromatin occurs via its recog-
nition of acetylated histone residues36,37,48,49. However, previous
studies disagreed on which precise histone modifications are
responsible for BRD4 recruitment49–51. Our data show that the
NSL complex contributes to chromatin recruitment of BRD4 in
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This is in agreement with a recent small-scale study in human
cells showing that depletion of MOF and subsequent reduction in
H4K16ac correlate with loss of BRD4 from promoters of several
autophagy-related genes50. Nevertheless, since combinatorial
effects of multiple acetylated histone residues enhance the affinity
of BET proteins to histones (Supplementary Fig. 5 and
refs. 36,38,48), it is likely that additional acetyl-marks on the his-
tone octamer, mediated by other histone acetyltransferases, such
as P300, may also impact on chromatin recruitment of BRD4
and dBRD4.
Our work reveals the significant extent to which BRD4 con-
tributes to expression of constitutive genes. Most previous
analyses of BRD4 had focused almost exclusively on its role at
developmental targets. The current hypothesis for the effect of
BRD4 inhibitor treatment against leukemia is that the action of
key developmental transcription factors, such as MYC, is blocked
upon BRD4 inhibition28,49,52,53. Regulation of housekeeping
genes by BRD4, however, raises the intriguing possibility that in
addition to the known deregulation of key transcription factors,
the sensitivity of leukemia cells to BRD4 inhibition could in part
be explained by a generally higher demand of cancer cells for
housekeeping gene products. Indeed, higher proliferation rates in
cancer cells compared to healthy cells are connected to a higher
need of metabolism and cell cycle-related proteins54. Thus,
Fig. 6 The NSL complex/BRD4 axis is conserved in mice and humans. a RT-qPCR analyses of Kansl2fl/fl, Cre-ERT2 mESCs with (Kansl2 KO) and without
(Kansl2 WT) tamoxifen treatment (500 nM, 3 days), and dBET6-treated (100 nM, 4 h) Kansl2 WT cells, see also Supplementary Fig. 6. Expression is
normalized to HPRT and relative to Kansl2WT. b ChIP-qPCR of BRD4 in Kansl2 KO, Kansl2WT and dBET6-treated mESCs. ChIP enrichments are relative to
gene desert signal. Primers target KANSL2-responsive (target) and KANSL2-non-responsive (control) genes. a, b Bars represent mean ± SEM (n= 3, for
dBET ChIP n= 2 biological replicates). Source data are provided as a Source Data file. c Heatmap of row-scaled normalized RNA-seq counts from fibroblast
cell lines of three Koolen-de Vries/KANSL1 haploinsufficient (KANSL1+/−) patients and four controls (for genes FDR < 0.2). Order was generated by
unsupervised hierarchical clustering. Genes significantly downregulated (DE down) (FDR < 0.05) upon JQ1 treatment in MOLT4 cells33 are indicated in
black, upregulated (DE up) or not differentially expressed (not DE) in white. d Left, log2 fold changes of conserved, NSL complex-dependent genes for NSL1
RNAi in Drosophila (FDR < 0.05), and Kansl3 knockdown in mESCs (FDR < 0.05,11). Right, row-scaled normalized RNA-seq counts of KANSL1+/− patients
and controls (FDR < 0.4). Red dot indicates association with GO term Metabolic Process. e Ingenuity Pathway Analysis showing most affected Disease and
Functions groups of DE genes (FDR < 0.1) obtained from DESeq2 analysis of KANSL1+/− patient fibroblast RNA-seq. Grey Z-score indicates NA. Boxes are
sized by negative log p-value. f Boxplots of log2 fold change of KANSL1+/− patient fibroblasts versus controls for classes of genes, based on differential
expression upon JQ1 treatment33: DE down (n= 5581), DE up (n= 1482), not DE (n= 3716). Boxplots show median (centre), interquartile-range (box)
and minima/maxima (whiskers).Two-sided Wilcoxon-rank-sum test was applied. g Left and middle: percentage of genes whose mouse orthologues
are promoter-bound by KANSL3 (n= 3665)(left) or MSL2 (n= 846) (middle) in mESC and downregulated (black bars) or upregulated (grey bars) in
KANSL1+/− patients. Right: percentage of genes significantly downregulated (FDR < 0.05) upon JQ1 treatment in MOLT4 cells (n= 5581)33 and down-or
upregulated in KANSL1+/− patients. Up/down classification of patient gene expression indicates directionality. Overrepresentation of downregulated
genes was tested with one-sided Fisher’s exact test.
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Fig. 7 Model of transcriptional activation of NSL complex target genes. Generating a functional NSL complex interactome (represented as a blue network,
left) enabled identification of BRD4 as the key interaction partner of the NSL complex in driving transcription of essential genes in Drosophila, mice and
humans. Molecular characterization of this interaction led us to propose the following model (right): The NSL complex recruits BRD4 to target promoters via
acetylation of the histone H4 tail, while BRD4 is required for the transition of RNA Pol2 from transcription initiation to elongation. Disturbance of the NSL
complex–BRD4 axis by BET inhibitors (BETi) or KANSL1 haploinsufficiency (as seen in Koolen-de Vries syndrome) results in transcription elongation defects
and compromised cellular homeostasis. BRD4 targeting defects can be restored by treatment with HDAC inhibitor (HDACi).
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inhibiting housekeeping gene transcription would render cancer
cells more susceptible to treatment than healthy less proliferating
cells. Consistently, a recent study identified MOF and BRD4 as
important factors for MLL-AF9 leukomogenesis55. It remains to
be explored, if and how the misregulation of housekeeping genes
affects cancer proliferation in the context of BRD4.
Our genome-wide analyses on patient fibroblasts and mouse
embryonic stem cells indicate that reduction of the NSL complex
at target gene promoters is associated with gene misregulation in
KANSL1-haploinsufficient patients. Although this molecular
causality is implied56, there is currently no targeted medical
treatment available for the Koolen-de Vries syndrome. Given that
expression data from patients revealed a BET protein signature,
and dBRD4 targeting defects could be rescued by HDACi treat-
ments, it is tempting to speculate that restoring acetylation levels
in patients could possibly revert gene misexpression and conse-
quently alleviate some of the symptoms associated with the
Koolen-de Vries syndrome.
HDACi treatment, when tested in the context of diseases linked
to acetylation imbalance, has already given promising outcome in
cellular model systems57 and was effective against epilepsy in
patients carrying KAT8 mutations9. In future, it would be
important to determine the contribution of BRD4 to the cellular
response to HDACi.
Our study uncovers a conserved crosstalk between the NSL
complex and BRD4 for the transcription regulation of a diverse
repertoire of common target genes. This crosstalk links a
housekeeping gene regulator (NSL complex) to a well-known,
disease-relevant protein (BRD4). This, together with our expres-
sion analysis from Koolen-de Vries patients, puts forward the
concept that the breadth of constitutive gene functions confers
disease relevance.
Methods
Cell culture. Drosophila S2 cells (Thermo Fisher R69007) were cultured at 25 °C in
serum free medium (Express Five SFM, Gibco), supplemented with 20 mM L-
Glutamin (GlutaMAX, Gibco). Cells were passaged with 10% of conditioned
medium each passage. Cells were maintained at a density of 1–12million ml−1.
Mouse embryonic stem cells were cultured in a humidified incubator at 37 °C
and 5% CO2. Cells were grown on Attachment Factor (Thermo Fisher) in 2i
medium (KnockOutTM Dulbecco’s modified Eagle’s medium (DMEM) (Gibco)
supplemented with 15% KnockOutTM Serum Replacement (Gibco), 0.1 mM
MEAA (Gibco, non-essential aminoacid), 1 nM Na-Pyruvate (Gibco), 0.1 mM 2-
mercaptoethanol (Gibco), 4 mM L-Glutamin (GlutaMAX, Gibco), 5 μg ml−1
Insulin (Sigma), 50 U ml−1 Pen-Strep, 200 U ml−1 LIF (ESGRO), 1 μM PD0325901
(StemGent), 3 μM CHIR99021 (StemGent).
Human fibroblast cell lines were established from skin biopsies of confirmed
Koolen de-Vries syndrome patients and healthy controls. Cells were maintained in
in a humidified incubator at 37 °C and 5% CO2 in DMEM (GlutaMAX
supplement, Life Technologies), 100 U ml−1 penicillin, 100 μg ml−1 streptomycin
and 10% foetal calf serum (FCS). All fibroblast lines tested negative for Hepatitis B,
Hepatitis C, HIV and human Herpes virus 4 and 8. Fibroblasts were passaged at
~90% confluency.
Human research participants. The affected individual and/or their families gave
written consent for their inclusion in the analysis under two local ethic committees
—approved protocol (S60206) to Leuven University for control samples and (DC-
2008-735) to Université Grenoble-Alpes CHU for patient specimens.
Distribution of human samples used in the study is restricted, as consent from
the patient families is required for further use.
Cloning. Plasmids were generated by PCR-based restriction cloning. PCR ampli-
fication was performed using PrimeSTAR GXL DNA Polymerase (Takara). For
dBRD4-S-stable cell line, cDNA encoding for dBRD4-S was PCR amplified from
the Drosophila Gold Collection clone LD26482 (available though DGRC), using
primers with PacI and AscI restriction site overhangs (see Supplementary Data 3)
and cloned into a modified pCo-Blast vector (Thermo Fisher K5150-01), con-
taining a copper inducible MtnA promoter and a 3xFLAG-6xHis-Bio-6xHis cas-
sette for C-terminal tagging. For recombinant dBRD4-S expression, dBRD4-S
(aminoacids 1-1063) was amplified from cDNA as for dBRD4-S stable cell line (see
above), using primers with BamHI and HindIII restriction sites (see Supplementary
Data 3) and cloned into a customized pET28 vector containing a 6xHis-SMT3
cassette for N-terminal tagging. The vector for expression of the Schizosacchar-
omyces pombe GST-HP1SWI6 was constructed in a pGEX backbone.
Generation of dBRD4-S stable cell line. The dBRD4-S-Biotin pCo-Blast based
plasmid (see cloning) was transfected in S2 cells using effectene transfection
reagent (Qiagen), transfected cells were selected with 5 µg ml−1 Blasticidin (Gibco)
for 10days. Expression of dBRD4-S-Biotin was induced by addition of CuSO4
(1 mM final) for 16 h.
Mouse ethics statement. Animals were kept on a 12:12 h light–dark cycle and
provided with food and water ad libitum. Animal husbandry and all experiments
were approved by the committee on ethics of animal experiments of the state
Baden-Württemberg (Regierungspräsidium Freiburg).
Generation of mouse embryonic stem cells. Mouse embryonic stem cells were
derived from 8-weeks-old natural-timed, mated, pregnant females by immuno-
surgery according to58. Briefly, Kansl2fl/fl (tm1a(EUCOMM)Wtsi, purchased from
the international knockout mouse consortium (IKMC)) females were crossed with
Kansl2+/fl, CAG::CreERT2 (purchased from Jackson laboratory) males. Both
strains had been backcrossed with C57Bl/6J. E 3.0 dpc embryos were flushed from
the uterus and placed into drops of pre-equilibrated EmbryoMax KSOM medium
(Merck) supplemented with 0.1 mM MEAA (Gibco, non-essential aminoacid),
1 μM PD0325901 (StemGent) and 3 μM CHIR99021 (StemGent). Acid tyrode was
used to remove the zona pellucida. Embryos were then transferred to wells of a 4-
well plate containing KnockOutTM DMEM (Gibco) supplemented with 1 μM
PD0325901 (StemGent), 3 μM CHIR99021 (StemGent), 200 U ml−1 LIF (ESGRO)
and 20% rabbit anti-mouse serum (Sigma # M5774) and incubated for 1 h in a
humidified incubator at 37 °C and 5% CO2. Excess serum was removed by media
washes (KnockOutTM DMEM (Gibco) supplemented with 1 μM PD0325901
(StemGent), 3 μM CHIR99021 (StemGent), 200 U ml−1 LIF (ESGRO) and the
embryos were transferred for 30 minutes into droplets containing KnockOutTM
DMEM (Gibco) supplemented with 1 μM PD0325901 (StemGent), 3 μM
CHIR99021 (StemGent) and 20% of freshly thawed complement sera from guinea
pig (Merck, #234395). Following careful washes, trophectoderm was separated
from the epiblast by pipetting up and down with a fine Pasteur pipette (smaller
than the inner cell mass (ICM)). Isolated epiblasts were cultured on gelatin-coated
plates in 2i medium (see Cell Culture subsection above). When the epiblasts had
reached their optimal size, they were disaggregated using Accutase (Sigma) and
transferred using a fine Pasteur pipette evaluating separation efficiency at a
stereomicroscope.
Drosophila husbandry. Drosophila melanogaster were reared on a standard
cornmeal fly medium at 25 °C, 70% relative humidity and 12 h dark/12 h light
cycle. Experimental crosses for dBRD4-L-HA fly lines were conducted at RT. The
following stocks were used:
w1118;P{da-GAL4.w‐}3 (Bloomington stock #8641)
w;; UAS-Fs(1)h.L::HA (Bohmann laboratory)
RNAi in Drosophila S2 cells. Production of dsRNAs was performed in the fol-
lowing way: DNA template for in vitro transcription was generated by PCR (pri-
mers as listed in Supplementary Data 3), T7 in vitro transcription was carried out
using HiScribe T7 High Yield RNA Synthesis Kit (NEB) according to manu-
facturers’ instruction. RNA cleanup was performed using MEGAclear Transcrip-
tion Clean-Up Kit (Ambion). in all, 10 µg dsRNA were used per 1 × 106 cells. Cells
were harvested after 4 days. This method was adapted from a previously described
method59.
Drug treatments. Drug treatments were performed by adding the respective
reagent to the cell culture medium; timings as indicated in the figure legends. The
following inhibitors were used: JQ1 (1187, Cayman Chemicals, 5 µM), iBET 762
(10676, Cayman Chemicals, 1 µM), dBET6(Gray lab, 100 nM), Panobinostat LBH-
589 (404950-80-7, Biozol Diagnostica, 200 nM).
RNAi screen. HD2.0 library of dsRNAs was used. This library was designed using
the software NEXT-RNAi18, excluding low complexity regions and sequence motifs
inducing off-target effects. 14000 protein coding genes and 1000 non-coding genes
are targeted. The genome-wide RNAi screen was performed with two technical
replicates. Per well 1.4 × 104 cells were seeded in 384-well plates prespotted with
250 ng dsRNAs each. After 24 h cells were transfected with a plasmid mix of 3 ng
Renilla reporter (pRL-hsp70), 17.5 ng UAS-firefly reporter (pG5luc) and 0.87 ng
NSL3-Gal4 DBD activator (pAct5.1-NSL3-Gal4-DBD)15 per well using effectene
transfection reagent (Qiagen) according to manufacturer’s instructions. 3d post
transfection, cells were lysed and subjected to dual luciferase assay readout by
chemiluminescence with a Mithras LB940 plate reader (Berthold Technologies).
Each assay plate contained wells with positive control dsRNAs (NSL complex
members: NSL1, NSL3 and MOF), and negative control dsRNAs (GFP, GST, Diap-
1). Data were analysed using the online software CellHTS260 (http://web-cellhts2.
dkfz.de/cellHTS-java/cellHTS2/) version 2.16.0 with the following settings:
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normalization method: plate median; values not log transformed; summarize
values: by mean; normalization scaling method: multiplicative; variance adjust-
ment: no scaling; no viability function included. RNAi candidates with a change in
Renilla of more than two fold up or down (Supplementary Fig. 1g) were excluded
from further analysis and also from the subset library tested in the secondary
screen.
Secondary screen was performed like genome-wide screen, but with a subset
library consisting of 367 candidates, 302 with Z-score <−7.32 (NSL co-activators)
37 with Z-score > 3 (NSL antagonists) and 28 additional candidates of interest.
Luciferase assays (96-well plate format). Luciferase assays were performed as in
the genome-wide RNAi screen, but seeding 1 × 105 cells per well in a 96-well plate
prespotted with 1 µg dsRNA and transfecting a plasmid mix of 17 ng Renilla
reporter (pRL-hsp70), 100 ng UAS-Firefly reporter (pG5luc) and 3.12 ng nsl3-Gal4-
DBD activator (pAct5.1-nsl3-Gal4-DBD) per well, three technical replicates per
assay. For luciferase assays with inhibitor treatments, at time of treatment 10×(of
final) concentrated inhibitor or DMSO containing medium was added to the cell
culture medium. Readout was performed by chemi luminescence using the Dual
Luciferase Assay Kit (Promega) and a Centro LB plate reader (Berthold
Technologies).
Biolayer interferometry measurements. GST-HP1SWI6 and SMT3-dBRD4-S
proteins were recombinantly expressed in RosettaTM (DE3) Competent Cells by
induction with 0.25 mM IPTG at 20 °C overnight for HP1SWI6 and 1.5 h at 37 °C
for dBRD4-S. Bacteria were collected by centrifugation and flash frozen. For bio-
layer interferometry measurements bacteria were lysed by sonication in lysis buffer
(100 mM NaCl, 25 mM HEPES pH7.4, 2 mM beta-Mercaptoethanol, 0.1%
Tween20, 1x Complete Protease Inhibitors (Roche)) followed by centrifugation at
20000 rpm for 30 min. The soluble lysate was directly used for Bio-Layer Inter-
ferometry (BLI) measurements using a BLItz instrument (ForteBio) with the
Advanced Kinetics program and Dip and ReadTM High Precision Streptavidin
(SAX) Biosensors. Total protein amounts per lysate (uninduced, GST-HP1SWI6 and
SMT3-dBRD4-S) were measured by Bradford and adjusted. N-terminally bioti-
nylated histone H4 peptides (aminoacids 1-23) harboring acetylated lysine residues
were purchased from EpiCypher (H4 unmodified #12-0029, H4K16ac #12-0033,
H4K12ac # 12-0032, H4K12,K16ac # 12-0136, H4K5,8,12,K16ac # 12-0034) and
used at 1 µM concentration. The measurements were carried out using lysates from
uninduced bacteria as baseline. The signal from H4 unmodified peptide mea-
surements was subtracted from all experimental measurements. As control, the H4
ac peptide measurements were also performed with HP1SWI6 lysates, which were
previously tested to display binding to H3K9me3 modified peptides.
Immunoblotting. Proteins were separated by SDS-PAGE, transferred at 110 V to a
PVDF membrane in Tris-Glycine Transfer-Buffer. Membranes were blocked for
30min-1h in 5% BSA in TBS-0.1% Tween, then incubated with primary antibodies
overnight at 4 °C. Secondary HRP-coupled antibodies were used at 1:10 000
dilution for 1 h. Blots were developed using Lumi-Light Western Blotting substrate
(Roche) and imaged on a ChemiDoc XRS+machine (Biorad). Following primary
antibodies were used: dBRD4 (Paro lab, ID166, 1:1000), Pol2 ser2p (ab5095,
Abcam, 1:5000), Pol2 ser5p (ab5131, Abcam, 1:5000), Rpb3 (Akhtar lab, 1:1000),
H3 (ab10799, Abcam, 1:3000), NSL3 (Akhtar lab, 1:1000), MOF (Akhtar lab,
1:3000), H2A.V (61752, Active Motif, 1:2000), MCRS2 (Akhtar lab, 1:3000),
H4K16ac (07-329, Millipore, 1:3000), KANSL2 (HPA038497, Sigma, 1:1000),
BRD4(A301-985, Bethyl, 1:2000), ACTIN-HRP(sc-1616, Santa Cruz, 1:5000),
GAPDH-HRP (MA5-15738, Thermo Scientific, 1:5000), FLAG-HRP(A8592,
Sigma, 1:5000). Uncropped immunoblots are provided in Supplementary
Figure 8a–g.
RNA expression analysis. For transcriptomic analyses of Koolen de-Vries patient
and control fibroblasts, cells were grown in parallel with each biological replicate
representing a fibroblast cell line derived from a different individual. Three inde-
pendent fibroblast cell lines from Koolen de-Vries patients and four from healthy
individuals were used between passages 6 and 8. RNA was isolated using the
RNeasy kit (Qiagen) and libraries prepared using the Illumina TruSeq
preparation kit.
For Drosophila RNA seq experiments three biological replicates were conducted
with one passage difference between each of the replicates. RNA was extracted
using a Trizol based kit (Directzol, Zymo), according to the manufacturer’s
manual. Sequencing libraries were prepared according to Illumina’s TruSeq
Stranded Total RNA Library Prep protocol for total RNA sequencing. Relative to
total RNA amounts per sample, ERCC spikes were added before library
preparation. For NSL1 depletion, the ratio of total RNA/ total DNA per sample did
not change over the course of the experiment. Since the DNA amount per cell
should not change during a knockdown experiment, we use ERCC spike
normalized data as approximation of true transcript abundance for the Drosophila
RNA-seq data in this study. Libraries were sequenced on a HiSeq2500 (Illumina)
with a sequencing depth of 30 × 106 reads per sample (Drosophila samples) and
40 × 106 reads per sample (fibroblast samples).
For RT-qPCRs, cDNA was synthesized using the GoScriptTM Reverse
Transcription System (Promega) with random primers for all Drosophila
experiments and oligo(dT) primers for experiments from mammalian cells from
0.5–1 µg of total RNA, for mESC cDNA 10% Drosophila total RNA were added
prior to RT reaction. Expression of target genes was normalized to robustly not
changing genes in RT-qPCR experiments (HPRT for mESC, ATPsynbeta, sun and
SP1029 for Drosophila cells)
Quantitative real-time PCR. qPCR was performed using FastStart Universal
SYBR Green Mastermix (Roche) on a Roche LightCycler 480 with 300 nM final
primer concentration in 7 µl reaction volume. We corrected for primer efficiency
using serial dilutions.
RNA-seq analysis. For Drosophila samples, reads were mapped to the Drosophila
genome (dm6) using subreads61, transcripts were counted with htseq62 and dif-
ferential expression analysis was performed using DESeq263. Here ERCC spike
normalization was performed. ERCC spikes were added according to total RNA
amount per sample before library preparation. Spikes were mapped using STAR64
(default parameters) and counted using feature counts65 (default parameters).
DESeq2 on spike counts (again of three biological replicates per sample) was used
to calculate the size factor, which was used to normalize gene expression DESeq2.
Expression analysis by qPCR of another independent replicate was performed to
validate the RNA-seq results. RNA seq from fibroblast samples was processed using
Snakepipes. Reads were mapped to hg38 genome using STAR (default parameters)
and transcripts were counted using featureCounts. Differential expression analysis
was performed with DESeq263, comparing healthy control samples (n= 4) to
patient samples (n= 3). Pathway analysis for patient fibroblast samples were
performed using Ingenuity Pathway Analysis (Qiagen).
Chromatin Immunoprecipitation (ChIP) and library preparation. Drosophila S2
cells were fixed for 10 min in 1.8% of formaldehyde at 23 °C shaking. Fixation was
quenched by the addition of glycine (0.125M). Nuclei were enriched by the fol-
lowing wash steps (all washes 5 min each at 4 °C) 2x buffer A (10 mM HEPES pH
7.6, 10 mM EDTA, 0.5 mM EGTA, 0.25% Triton X-100, protease inhibitors), 3x
buffer B (200 mM NaCl, 10 mM HEPES pH 7.6, 1 mM EDTA, 0.5 mM EGTA,
0.01% Triton-X 100, protease inhibitors) and 3x RIPA buffer (25 mM HEPES pH
7.6, 150 mM NaCl, 1 mM EDTA, 1% Triton-X 100, 0.1% SDS, 0.1% DOC, protease
inhibitors). Sonication was performed in RIPA buffer, first 9 × 20 s using a Branson
250 sonicator at 40 pulse, intensity 2.5, then 12 min using a Covaris soncator E220
(following settings: peak power 150, duty factor 10, cycles/burst 200), yielding
fragment sizes of 250–500pb. After clearing the chromatin extract (10 min, 12000
g), supernatant was used for IP. Biotin ChIP experiments were performed as
described by66, with slight modifications. In brief, to 200 µg chromatin per IP were
diluted in RIPA buffer and added to 20 µl of streptavidin T1 magnetic beads
(Invitrogen) previously blocked for 1 h with 1% cold fish skin gelatin (Sigma
Aldrich) and 1 mg yeast tRNA (Ambion). Per 200 µg chromatin (as measured from
DNA absorption) × 130 pg biotin labeled DNA fragments were added to the IP.
Three different biotin spikes were generated by reverse transcription of ERCC RNA
spikes and amplification with biotin labeled primers. Chromatin was incubated
with streptavidin magnetic beads for at least 6 h at 4 °C. Beads were washed for 8
min at RT for each wash step, two washes in SDS wash buffer (2% SDS in TE buffer
(10 mM Tris-HCl, 1 mM EDTA)), 1 wash in high salt RIPA buffer (RIPA buffer
with 500 mM NaCl instead of 140 mM), 1 wash in LiCl buffer (250 mM LiCl,
10 mM Tris-HCl, 1 mM EDTA, 0.5% NP-40, 0.5% DOC), two washes in TE buffer.
Beads were reverse crosslinked overnight at 65 °C followed by RNAseA (Thermo
Scientific, 0.1 mg ml−1) (30 min 37 °C) and proteinase K digestion (Ambion, 0.1
mg ml−1) for (2 h at 55 °C). DNA was purified using minelute columns (Qiagen).
For ChIP of endogenous proteins 4 µl of NSL1, MOF, dBRD4 or Rbp3 antibody
were added to 10 µg chromatin, diluted in RIPA buffer and incubated at 4 °C
overnight. For Rbp3 ChIPs additional 2 µg of sheared Drosophila virilis chromatin
were added to each IP to be able to control for IP efficiencies. 20 µl blocked (as
streptavidin beads) magnetic protein A/G beads (Invitrogen) were used to capture
immunocomplexes (2 h at 4 °C). Washes of beads were done at 4 °C for 3 × 10 min
in RIPA buffer, 1 × 10 min in LiCl buffer, 1x TE buffer. Reverse crosslinking,
RNAse and ProtK digestion were done like for biotin ChIP, see above.
For ChIP in mESCs, cells were fixed for 10 min in 1.8% of formaldehyde at
23 °C shaking and quenched by addition of glycine (0.125 M). Isolation of nuclei
was performed like as for Drosophila cells. Then nuclei were sheared for 20 min in
10 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 0.1% DOC,
0.5% sodium dodecyl sarcosinate, 1% Triton X-100 29 using a Covaris soncator
E220 (following settings: peak power 105, duty factor 2, cycles/burst 200). IP,
washes, reverse crosslinking and cleanup of DNA was performed as for Drosophila
endogenous antibody ChIPs. ChIP-QPCR recovery was determined as the amount
of immunoprecipitated DNA relative to input DNA.
ChIP-sequencing libraries were prepared from 0.5–1 ng (for biotin IP) 2–10 ng
(for histone and Rpb3 IPs) using NEBNext Ultra2 Library Preparation Kit,
according to manufacturers’ manual, paired end sequencing was done on a
HiSeq3000 (Illumina), 75 bp read length, sequencing depth of ca. 10mio reads per
sample.
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ChIP-seq data analysis. Sequencing reads of ChIP samples and their respective
input samples were trimmed using TrimGalore (developed by Felix Krueger,
Babraham Institute) (quality threshold of 20), subsequently the reads were mapped
to the Drosophila genome (dm6) using Bowtie267 (default settings, no duplicate
removal). After mapping the BAM files of the two biological replicates of each
experiment were merged. If not indicated differently coverage of ChIP data was
normalized to input data by calculating log2 fold change of ChIP/input using
bamCompare and bamCoverage from deepTools268. For visualization of ChIP seq
tracks IGV was used. For Rpb3 ChIPs the ChIP/input enrichment was calculated
using Signal Extraction Scaling (SES) method. Enrichment of ChIP signal on
promoters (± 200bp from TSS for transcription factors +500 bp for histone marks)
was generated using MultiBigwigSummary tool from deepTools268.
Biotin ChIP efficiencies were assessed by mapping and counting the number of
reads mapping to a spike annotation for each sample (Bowtie2). Similarly Rpb3
ChIP efficiencies were assessed by mapping and counting the number of reads
assigned to the Drosophila virilis genome (Bowtie2, dvir1.3). As no major
differences in external spike numbers (biotin or Drosophila virilis spikes) could be
observed between the samples, standard normalization methods (log2 fold change
ChIP/input) were applied.
To generate the list of dBRD4-S-Biotin-bound genes, peaks of endogenous
dBRD4 ChIP and dBRD4-S-Biotin ChIP were called using MACS269 and the
following parameters: band width, 300; model fold, 5–50; p-value cut-off, 5 × 10−5;
both datasets were generated in this study. Whenever the called peak region
overlapped with TSS ± 200 bp the gene was defined as bound gene. The dBRD4-S-
Biotin-bound genes were only considered if the gene was also bound by
endogenous dBRD4.
Similarly, to calculate percentages of dBRD4 and NSL3 co-bound promoters,
peaks of endogenous dBRD4 ChIP25 and NSL3 ChIP13 were called using MACS2
(model fold, 10–30; p-value cut-off, 1 × 10−5 and model fold, 5 to 50; p-value cut-
off, 5 × 10−5). Whenever the called peak region overlapped with TSS ± 200 bp the
gene was defined as bound gene. The bound gene lists were then compared to
calculate overlaps. Gene Ontology (GO) Enrichment Analysis was conducted with
the GO Ontology database (Released 2019-07-01) using PANTHER
Overrepresentation test (Released 2019-07-11) with Fisher analysis on http://
geneontology.org/ and visualized using REVIGO (http://revigo.irb.hr/r).
Generating NSL complex-bound and non-bound gene lists. To generate the lists
of expressed, NSL complex-bound and non bound genes (Fig. 3) published NSL3
and MBDR2 profiles13 were analysed similar as above. Genes were filtered for
expressed genes (more than 10counts of mean expression in control RNAi RNAseq
dataset (this study)). Enrichment of ChIP signal of the promoter regions (±500 bp
from TSS) was generated using MultiBigwigSummary (deepTools2)68. Genes were
ranked according to NSL3 binding, based on visual inspection of grouped binding
profiles, a cutoff to distinguish bound from non-bound expressed genes was
chosen, such that lowly-bound genes were excluded from the non-bound gene list.
As the primary aim was to generate a stringent list of non NSL-bound expressed
genes, rather than a stringent list of NSL-bound genes. MBDR2 binding profiles
were used to verify that the lists represent NSL complex-bound and non-
bound genes.
Polytene chromosome immunostainings. Polytene stainings of salivary glands of
wandering third instar larvae were carried out as follows. Salivary glands were
dissected, fixed for 7 min in fixation solution (1.8% Formaldehyde, 0.45% acetic
acid), then transferred to a polylysine coated slide and covered with a coverslip.
Spreading of chromosomes was achieved by applying the tip of a 200 rpm Dremel
and subsequent flattening was achieved with the use of a MTC-300-1 vice (Avenger
Gold Toolmaker). Slides were blocked with 10% goat serum (Invitrogen), followed
by primary and secondary antibody incubations. Primary antibodies were used at
the following concentrations: anti HA (Covance) 1/400, anti NSL3 1/250, Sec-
ondary Antibodies were used at 1/500 dilution. Images were captured on a LSM780
confocal microscope (Carl Zeiss Microscopy) using an alpha Plan-Apochromat
63×/1.4 (DIC) Oil objective. This method was adapted from a previously described
method70.
Generating list of conserved NSL complex-dependent genes. Genes down-
regulated following NSL1 RNAi in Drosophila cells (FDR < 0.05), Kansl3 shRNA
treatment in mESC11 (FDR < 0.05) and genes downregulated in Koolen-de Vries
patients (FDR < 0.4) were overlapped. Orthologue predictions were obtained from
Ensembl BioMart.
Data from public repositories. From NCBI gene expression omnibus (GEO)
(http://www.ncbi.nlm.nih.gov/geo/)
dBRD4 ChIP-seq from S2 cells: GSE36450
MOF ChIP-seq: GSE37864
KANSL3, MCRS1, MOF ChIP-seq in mESC: GSE51746
Kansl3 knockdown RNA-seq in mESC: GSE57698
BRD4 ChIP-seq: mESC and EB: GSE76760
BRD4 ChIP-seq: MLL-AF9: GSE74536
JQ1 RNA-seq MOLT4 cells: GSE79253
From ArrayExpress
NSL3 and MBD-R2 ChIP-seq from S2 cells: E-MTAB-1085
Pol II ChIP-seq from S2 cells (GFP RNAi, NSL1 RNAi): E-MTAB-1084
Reporting summary. Further information on experimental design and reagents
can be found in the Nature Research Reporting Summary linked to this article.
Data availability
RNA-seq and ChIP-seq data have been deposited to Gene Expression Omnibus (GEO)
under the accession number: GSE135815 and are also accessible under BioProject
PRJNA560185. All other relevant data supporting the key findings of this study are
available within the article and its Supplementary Information files or from the
corresponding author upon reasonable request.
The source data underlying Figs. 2a, 3b–d, 4d–g, 5b, 6a,b and Supplementary Figs. 1a,
b, 3a–c, 4b, 4g,h, 5f,g, 6c–e, 7a,b are provided as Source Data files.
Code availability
All data analyses used were performed using published software. Requests can be sent to
the corresponding author.
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